Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: MarketLine (a Datamonitor Company)

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NeuroSearch to adjust FY 2012 annual report; maintains FY 2014 outlook

Friday, 21 Feb 2014 08:03am EST 

NeuroSearch A/S:The Danish Business Authority says the company incorrectly classified the proceeds from the sale of the Huntexil project as revenue in financial statement for 2012.The proceeds ought to have been classified as gain from divestment of intellectual property.NeuroSearch will issue an adjusted annual report.The adjustment does not affect neither the company's results, equity nor the cash flows.In FY 2014, NeuroSearch still expects an operating loss of about 10 million Danish crowns. 

Company Quote

2 Jul 2015